Windlas Biotech's Stock Price Soars 9.22%, Outperforms Sector and Sensex

Windlas Biotech, a smallcap pharmaceutical company, has seen a significant increase in its stock price on October 29, 2024. The stock has gained 9.22%, closing at Rs 1035.75. MarketsMOJO has given a 'Hold' call for the stock.

The stock is currently trading close to its 52-week high, with only a 3.06% difference. It has also outperformed the sector by 10.23% today. This marks a trend reversal for the stock, as it has gained after two consecutive days of falling.

Windlas Biotech has shown high volatility today, with an intraday volatility of 6.91%. The stock touched an intraday high of Rs 1045.95, which is an 11.07% increase from its previous close. The weighted average price has been used to calculate the volatility.

In terms of moving averages, Windlas Biotech is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the stock.

In comparison to the Sensex performance, Windlas Biotech has outperformed with a 1-day performance of 6.97% while the Sensex has only shown a 0.25% increase. In the past month, Windlas Biotech has also outperformed the Sensex with a 21.63% increase, while the Sensex has shown a -6.27% decrease.

Overall, Windlas Biotech has shown a strong performance in the stock market, with positive trends and outperforming the sector and Sensex. Investors may want to consider holding onto their shares for now, as suggested by MarketsMOJO's 'Hold' call.